NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good ca...
香雪制药 TAEST16001注射液治疗肿瘤抗原NY-ESO-1表达阳性、基因型为HLA-A*02:01的晚期软组织肉瘤。 此前,2期临床结果比较积极,被国家药监局纳入突破性疗法。 近日,香雪制药新追加了一个临床安排,猜测是进入了临床三期试验。 祝贺! 当然了,二级市场可能或多或少知道了这个结果,提前进行了炒作! 注意风险! $香雪...
Recombinant Human NY-ESO-1 (HLA-A*02:01) Protein is expressed from HEK293 Cells with His tag and Avi tag at the C-terminal.It contains Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and SLLMWITQCpeptide. Molecular Weight The protein has a predicted MW of 50.5 kDa. Due to glycos...
中文名称: Biotinylated Monomer – HLA-A*02:01 NY-ESO-1 C9V (SLLMWITQV) (formerly code #MR01076A) 中文同义词: 英文名称: Biotinylated Monomer – HLA-A*02:01 NY-ESO-1 C9V (SLLMWITQV) (formerly code #MR01076A) 英文同义词: Biotinylated Monomer – HLA-A*02:01 NY-ESO-1 C9V (...
河南省肿瘤医院免疫治疗科正在开展使用靶向HLA-A*02:01/NY-ESO-1靶点的TCR-T细胞治疗转移性实体瘤(食管癌、黑色素瘤、滑膜肉瘤、脂肪肉瘤等软组织肉瘤)的临床研究,计划招募15名转移性实体瘤患者,观察使用TCR-T细胞治疗后的抗肿瘤效果,并全程监测该细胞使用的安全性及初步疗效。本研究已经通过河南省肿瘤医院伦理委员...
TAEST16001治疗肿瘤抗原NY-ESO-1表达阳性、基因型为HLA-A*02:01的晚期软组织肉瘤的多中心、开放、单臂、II期临床研究项目名称,国科遗办审字〔2022〕GH5820号审批号,遗传资源国际合作审批类型,中山大学肿瘤防治中心医疗机构,广东医疗机构所在省份,来源于药智数据中国人类遗
中文名称: iTAg Tetramer/PE – HLA-A*02:01 NY-ESO-1 (SLLMWITQC) 中文同义词: 英文名称: iTAg Tetramer/PE – HLA-A*02:01 NY-ESO-1 (SLLMWITQC) 英文同义词: iTAg Tetramer/PE – HLA-A*02:01 NY-ESO-1 (SLLMWITQC) CAS号: 分子式: 分子量: 0 EINECS号: Mol文件: Mol File ...
TAEST16001治疗肿瘤抗原NY-ESO-1表达阳性(基因型为HLA-A*02:01)的以软组织肉瘤为主的晚期恶性实体瘤患者的开放、单臂、早期临床研究受试者招募一、试验设计简介本研究是一项开放、单臂、剂量递增的早期临床...
英文名: HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His & Avi), Biotinylated描述: NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit ...
英文名: HLA-A*02:01&B2M&NY-ESO-1 (SLLMWITQV) Monomer Protein, Human, MHC (His & Avi)描述: NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral ...